Resolution Bioscience

Resolution Bioscience, headquartered in Kirkland, Washington, is a biotechnology company comprised of 28 employees. The company generates approximately $50 million in annual revenue. Resolution Bioscience, a subsidiary of Agilent, specializes in developing innovative cancer diagnostics. Their core focus is on creating next-generation cancer diagnostics, enabling physicians to personalize cancer treatments based on liquid biopsies. Their proprietary molecular analytics platform analyzes cell-free DNA, providing actionable insights previously only obtainable through invasive biopsy procedures. Resolution Bioscience offers over 50 specialized panels and is actively developing companion diagnostics to support therapeutic approvals. Resolution Bioscience distinguishes itself through its commitment to improving cancer patient outcomes. Their suite of clinical tests aims to guide the selection of targeted therapies and monitor their effectiveness throughout treatment. For more information, visit resolutionbio.com.